Genetic variants on Chr2 and Chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment

Details for Australian Patent Application No. 2008231425 (hide)

Owner deCODE Genetics ehf

Inventors Manolescu, Andrei; Sulem, Patrick; Stacey, Simon

Agent Freehills

Pub. Number AU-A-2008231425

PCT Pub. Number WO2008/117314

Priority 8648 25.05.07 IS; 8625 26.03.07 IS

Filing date 26 March 2008

Wipo publication date 2 October 2008

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/117314 Priority application(s): WO2008/117314

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008231441-Thiazolidine derivatives as orexin receptor antagonists

2008231424-Polymer particles based vaccine